The gap between a 6.30 trailing P/E and a 12.71 forward P/E implies the market expects earnings to fall further before recovering, since forward estimates are higher than the trailing base only if the trailing period was distorted by elevated depressed-margin quarters. The 0.10 PEG and 29.2% dividend yield are unusual and likely reflect a payout tied to recent elevated cash generation, which warrants scrutiny of sustainability. Investors should monitor whether the discount persists once normalized earnings are established.

This compression suggests the company remains a price-taker on feed-to-meat spreads rather than having durably shifted toward higher-margin branded mix, since the margin reversal occurred despite the stated value-added strategy. Net margin dropping to 2.5% in the latest quarter indicates that below-the-line items are absorbing a meaningful share of operating gains. Normalized earnings power appears closer to the lower end of the recent range than to the mid-2025 peak.

The decline is driven primarily by margin compression rather than capital efficiency, as asset turnover held near 0.44 to 0.47 throughout the period. Growing net PP&E alongside falling returns suggests recent capital deployment has not yet translated into proportionate earnings, which may indicate timing lags or underperforming capacity. Whether returns recover depends largely on whether feed-to-meat spreads normalize, a dependency that warrants further investigation.

Coverage deterioration appears to stem from falling operating income rather than a sharp increase in interest costs, which implies that earnings volatility, not balance sheet structure, is the primary constraint. D/EBITDA climbing from 5.38 to 11.64 reflects the same earnings compression and could indicate reduced cushion if margins stay depressed. Refinancing risk appears manageable on reported figures, though the trend merits close monitoring.